業績 - NPO法人横浜臨床腫瘍研究会YCOG NPO法人横浜臨床腫瘍研究会YCOG

業績

YCOG1001: Ozawa M, Watanabe J,Ishibe A,Goto K,Fujii Y,Nakagawa K,Suwa Y,Suwa H,Masui H,Sugita M,Mochizuki Y,Yamaguchi S,Hasegawa S,Homma Y,Momiyama M,Kumamoto T,Matsuyama R,Takeda K,Taguri M, Endo I:Multicenter randomized phase II study on S‑1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).Cancer Chemotherapy and Pharmacology. January 29,2024. doi:https://doi.org/10.1007/s00280-024-04648-6
YCOG1002: stageⅢ結腸癌に対する術後補助化学療法としてのCapecitabine経口療法におけるリン酸ピリドキサールの手足症候群(Hand foot Syndrome)抑制効果
Ota M, Tatsumi K, Suwa H, Watanabe J, Watanabe K, Osada S, Tanaka K, Fujii S, Ichikawa Y, Kunisaki C, Endo I: The effect of pyridoxine for prevention of hand-foot syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: a randomized study. Hepato-Gastroenterology, 61 : 1008-1013, 2014.
YCOG1003: Matsuyama R, Matsuo K, Mori R, Sugita M, Yamaguchi N, Kubota T, Kameda K, Mochizuki Y, Takagawa R, Kadokura T, Matsuda G, Kamiya N, Endo I: Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group. In Vivo, 35(2): 1217-1225, 2021.
YCOG1004: Familial adenomatous polyp (FAP)の外科治療成績の検討
Hideaki Kimura, Hirokazu Suwa, Takuji Takahashi, Kazuteru Watanabe, Sadatoshi Sugae, Shuji Saito, Toru Kubota, Kazutaka Koganei, Akira Sugita, Shoichi Fujii, Mitsuyoshi Ota, Yasushi Ichikawa and Itaru Endo
Long-Term Outcomes After Colectomy in Patients With Familial Adenomatous Polyposis
International Surgery 101, 9-10 , 400-405, 2016
YCOG1005: Yamamoto S, Narui K, Ishikawa T, Adachi S, Shimada K, Shimizu D, Yamada A, Sugae S, Tanabe M, Oba M, Morita S, Doi T, Hasegawa S, Morita T, Kito A, Chishima T, Ichikawa Y, Endo I; YOKOHAMA CLINCAL ONCOLOGY GROUP: First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study. Anticancer Res, 41(3): 1671-1676, 2021
YCOG1006: 胃癌術後縫合不全発生の危険因子に関する研究
Kosaka T, Akiyama H, Makino H, Kimura J, Takagawa R, Ono H, Kunisaki C, Endo I:Impact of Neoadjuvant Chemotherepy Among Patients with Pancreatic fistula after Gastrectomy for Advanced Gastric Cancer.Anticancer Resreach,36:1773-7,2016
YCOG1007: 胃GISTの研究
2014年9月 Anticancer Res.34 に掲載
『Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST』
Miyamoto H,Kunisaki C,Otsuka Y,Takahashi M,Takagawa R,Misuta k,Kameda K,Makino H,Matsuda G,Yamaguchi N,Kamiya N,Murakami T,Morita S,Akiyama H,Endo I
YCOG1008: Abdominal drainage may be a risk factor for surgical site infection following appendectomy.
Murakami T, Wada T, Ishibe A, Akiyama H, Endo I.
Asian J Surg. 2019 Sep;42(9):897-898. doi: 10.1016/j.asjsur.2019.05.007. Epub 2019 Jun 21.

YCOG1012: Kida K, Yamada A, Shimada K, Narui K, Sugae S, Shimizu D, Doi T, Oba M, Endo I, Ishikawa T; A prospective comparison study utilizing patient‑reported outcomes of taxane‑related peripheral neuropathy between nab‑paclitaxel and standard paclitaxel in patients with breast　cancer(YCOG1012).Breast Cancer.Feb 2024. DOI: https://doi.org/10.1007/s12282-024-01551-z
YCOG1013: A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer.
Tanaka Y, KunisakiC, IzumisawaY, Makino H, Kimura J, Sato S, Miyamoto H, Kosaka T, Ono HA Takahashi M, Sato K, Akiyama H, Endo I.
Anticancer Res. 2018 Oct;38(10):6015-6021.
YCOG1102: Watanabe K,Ishibe A,Watanabe J,Ota M,Fujii S,Ichikawa Y,Oba MS,Endo I；The Effect of TJ-28 (Eppikajutsuto)
on the Prevention of Hand-Foot Syndrome Using Capecitabine for Colorectal Cancer: The Yokohama Clinical
Oncology Group Study (YCOG1102) .Indian Journal of Gastroenterology, 39: 204–210, 2020

YCOG1105

Sugita M, Endo I, Matsuyama R, Akiyama H, Takeda K, Kunisaki C: Perioperative Risk and Prognostic Factors for Pulmonary Thromboembolism Developing after Abdominal Surgery(YCOG1105 Study). 日本外科系連合学会誌, 46(5): 539-547,2021.

YCOG1107

Sato K, Kunisaki C, Kosaka T, Takagawa R, Takahashi M, Izumisawa Y, Miyamoto H, Sato S, Tanaka Y, Yamaguchi N, Kimura J, Hidetaka A.Ono, Makino H, Akiyama H, Endo I: Multicenter phase Ⅱ study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107: Cancer Chemother Pharmacol,DOI 10.1007/s00280-017-3430-6.

YCOG1108

大腸癌イレウスにおける腸管減圧法別の治療成績の検討
Ishibe A, Ota M,Yamaguchi K, Kaida S, Kamiyama N, Momiyama M, Watanabe A, Sekizawa K, Kamimukai N ,Sugimasa N ,Watanabe J ,Ichikawa Y ,Kunisaki C ,Endo I:Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer.:A multicenter retrospective cohort study.World Journal of Gastroenterology22:5237-5245,2016.

YCOG1109

直腸癌術後直腸膣瘻症例のretrospective study
Watanabe J, Tatsumi K, Ota M, Suwa Y, Suzuki S, Watanabe A, Ishibe A, Watanabe K, Akiyama H, Ichikawa Y, Morita S, Endo I: The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer. Int J Colorectal Dis, 29 : 343–351, 2014.

YCOG1202: 小笠原康夫,上田倫夫,南　裕太,松山隆生,國崎主税,遠藤　格；腹腔鏡下胆嚢摘出術における胆道損傷についての多施設共同研究(YCOG1202).日本外科系連合学会誌, 45(2): 95-102, 2020
YCOG1203: Predictive factors for bile leakage after hepatectomy for hepatic tumors: a retrospective multicenter study with 631 cases at Yokohama Clinical Oncology Group (YCOG).
Nakagawa K, Tanaka K, Nojiri K, Sawada Y, Kumamoto T, Ueda M, Minami Y, Mochizuki Y, Morioka D, Kubota T, Kamiya N, Yoshida K, Yonemoto N, Endo I.
J Hepatobiliary Pancreat Sci. 2017 Jan;24(1):33-41. doi: 10.1002/jhbp.411.
YCOG1205: High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T, Matsuyama R, Ueda M, Mochizuki Y, Homma Y, Kameda K, Yazawa K, Izumisawa Y, Fukushima T, Kamimukai N, Yoshida K, Kamiya N, Hoffman RM, Endo I.
World J Surg Oncol. 2019 Aug 9;17(1):140. doi: 10.1186/s12957-019-1675-8.
YCOG1207: Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox(YCOG1205).
SuwaY, Watanabe J, Ota M, Suzuki S, SuwaH, Watanabe K, Saito S, NagamineK, MomiyamaM IshibeA, SaigusaY, Yamanaka T, Endo I.
Cancer ChemotherPharmacol. 2019 Mar;83(3):419-424.

YCOG1301: Takei S,Ishibe A,Watanabe J,Watanabe K,Suwa Y,Suzuki S,Nakagawa K,Suwa H,Ota M,Ichikawa Y,Kunisaki C,Yamanaka T,Endo I；
Risk factors of chemotherapy-induced nausea and vomiting in patients with metastatic colorectal cancer: a prospective cohort study (YCOG1301).
Int J Colorectal Dis . 2020 Aug 28. doi: 10.1007/s00384-020-03731-7. Online ahead of print.
YCOG1303: Mikami Y, Yamada A, Suzuki C, Adachi S, Harada F, Yamamoto S, Shimada K, Sugae S, Narui K, Chishima T, Ishikawa T, Ichikawa Y, Endo I: Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study. J Surg Res, 264: 45-50, 2021.
YCOG1304: 大腸NETの検討
渡部顕，大田貢由，諏訪雄亮，鈴木紳祐，石部敦士，渡邉純，渡辺一輝，市川靖史，平澤欣吾，田辺美樹子，遠藤格：WHO 2010に基づく大腸神経内分泌腫瘍の再評価．日本大腸肛門病学会誌，68：61-67，2015．
YCOG1305: Ishibe A, Watanabe J, Suwa Y, Nakagawa K, Suwa H, Misumi T, Ota M, Endo I: A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG 1305 (PROBE study). Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004494.
YCOG1306: A Comparative Study of Intravenous Injection Form and Oral Jelly Form of Alendronate Sodium Hydrate for Bone Mineral Disorder after Gastrectomy. Kunisaki C, Tanaka Y, Kosaka T, Miyamoto H, Sato S, Suematsu H, Yukawa N, Sato K, Izumisawa Y, Akiyama H, Taguri M, Yamanaka T, Endo I.
Digestion. 2017;95(2):162-171. doi: 10.1159/000458755. Epub 2017 Feb 18.
YCOG1307: The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307).
Toritani K, Watanabe J, Suwa Y, Suzuki S, Nakagawa K, Suwa H, Ishibe A, Ota M, Kunisaki C, Endo I.
Int J Colorectal Dis. 2019 Oct;34(10):1697-1703. doi: 10.1007/s00384-019-03374-3. Epub 2019 Aug 30.

Kakizoe M, Watanabe J, Goto K, Suwa Y, Nakagawa K, Suwa H, Ozawa M, Ishibe A, Ota M, Kunisaki C, Endo I: Identification of Patients with Locally Advanced Rectal Cancer in Whom Preoperative Radiotherapy Can Be Omitted: A Multicenter Retrospective Study at Yokohama Clinical Oncology Group (YCOG1307): J Anus Rectum Colon, 5(2): 173-180, 2021.
YCOG1402: Suwa Y, Watanabe J, Suwa H, Ozawa M, Momiyama M, Ishibe A, Nagamine K,Yamagishi S,Ota M, Fukushima T,Sekido H, Saigusa Y:Exploratory randomized phaseⅡtrial for optimizing treatment dosage and duration of adjuvant S-1 plus oxaliplatin in patients with stageⅢcolon cancer:YCOG1402(SOAP trial).AGSurg.2023.April16. DOI:10.1002/ags3.12687

YCOG1404: Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404).
Nakagawa K, Watanabe J, Ota M, Suwa Y, Suzuki S, Suwa H, Momiyama M, Ishibe A, Saigusa Y, Yamanaka T, Kunisaki C, Endo I.
Surg Today. 2020 Jan;50(1):68-75. doi: 10.1007/s00595-019-01859-w. Epub 2019 Aug 5.
YCOG1405: A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer.
Sato S, KunisakiC, Tanaka Y, Sato K, Miyamoto H, Yukawa N, FujiiY, Kimura J, Takagawa R Takahashi M, Kosaka T, Akiyama H, SaigusaY, Taguri M, Yamanaka T, Endo I.
Anticancer Res. 2018 Dec;38(12):6911-6917.
YCOG1406: Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns. Harada F, Matsuyama R, Mori R, Kumamoto T, Morioka D, Taguri M, Yamanaka S, Endo I.
Eur J Surg Oncol. 2019 May;45(5):761-768. doi: 10.1016/j.ejso.2018.10.532. Epub 2018 Oct 24.
YCOG1601: Sato S, Kunisaki C, Tamura Y, Yago A, Kasahara K, Sato T, Kondo H, Kosaka T, Akiyama H, Endo I;Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601).Anticancer Research Dec 2023, 43 (12) 5663-5670; DOI: https://doi.org/10.21873/anticanres.16771
YCOG1603: Ohya H, Watanabe J, Suwa Y, Nakagawa K, Suwa H, Ozawa M, Ishibe A, Kunisaki C, Endo I: Comparison of the continuation and discontinuation of perioperative antiplatelet therapy in laparoscopic surgery for colorectal cancer: A retrospective, multicenter, observational study (YCOG 1603). Ann Gastroenterol Surg. 2020;00:1–8.DOI: 10.1002/ags3.12387.
YCOG1701: Suzuki C, Yamada A, Kawashima K, Sasamoto M, Fujiwara Y, Adachi S, Oshi M, Wada T, Yamamoto S, Shimada K, Ota I, Narui K, Sugae S, Shimizu D,Tanabe M, Chishima T, Ichikawa Y,Ishikawa T, Endo I:Clinicopathological Characteristics and Prognosis of TripleNegative Apocrine Carcinoma: A Case-Control Study (YCOG1701).World J Oncol. accepted September 12, 2023. doi: https://doi.org/10.14740/wjon1694
YCOG1801: Chida K, Watanabe J, Hirasawa K, Inayama Y, Misumi T, Kunisaki C, Endo I: A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors. Ann Gastroenterol Surg, 4(5): 562-570, 20
YCOG1903: Watanabe J, Suwa Y, Goto K, Nakagawa K, Ozawa M, Ishibe A, Suwa H, Kunisaki C, Endo I: Randomized controlled trial evaluating the efect of the use of a laparoscopic lens cleaning device during laparoscopic colorectal surgery on the multidimensional workload(YCOG1903). Surgical Endoscopy. 2023.Mar 9. doi:10.1007/s00464-023-09972-1.
YCOG2003: Sato S, Kunisaki C, Kondo H, Tsuchiya N, Tanaka Y, Takahashi M, Sato K, Kimura J, Ono HA, Makino H, Tamura Y, Kasahara K, Kosaka T, Akiyama H, Endo I: Is Prophylactic Splenectomy Necessary for Proximal Advanced Gastric Cancer Invading the Greater Curvature with Clinically Negative Splenic Hilar Lymph Node Metastasis? A Multi-Institutional Cohort Study (YCOG2003). Ann Surg Oncol, 29(9): 5885-5891, 2022.
YCOG2004: Takei S,Watanabe J,Ishibe A,Suwa Y,Nakagawa K,Ozawa M,Suwa H,Misumi T,Kunisaki C,Endo I: Study protocol: a multicenter randomized controlled trial to evaluate the length of hospital stay of intracorporeal versus extracorporeal anastomosis in laparoscopic colectomy for colon cancer (CONNECT study). Int J Colorectal Dis. 2021 Feb 2. doi: 10.1007/s00384-021-03869-y.
YCOG2005: Ohya H, Watanabe J, Goto K, Suwa Y, Nakagawa K, Ozawa M, Sato S, Sugano N, Suwa H, Ishibe A, Kunisaki C, Endo I: Study protocol: a multicenter randomized controlled trial of the multifaceted workload reduction of the anti-adhesion barrier for diverting ileostomy in laparoscopic rectal surgery, YCOG 2005 (ADOBARRIER study). Int J Colorectal Dis, 36(12): 2763-2768, 2021.
YCOG2101: 閉塞性大腸癌の治療成績に関する多施設共同後ろ向き観察研究 Nakagawa K, Ishibe A, Ohya H, Ozawa M, Suwa Y, Watanabe J, Suwa H, Den K, Mori K, Momiyama M, Goto K, Endo I:Effects of neoadjuvant chemotherapy for patients with obstructive colon cancer: A multicenter propensity score-matched analysis (YCOG2101).Ann Gastroenterol Surg. 2023;00:1–11.,DOI: 10.1002/ags3.12736,2023
YCOG2202: Kondo H, Sato S, Kunisaki C, Tanaka Y, Sato K, Kimura J,Kosaka T, Ono HA, Makino H, Akiyama H, Endo I:Prognostic factors in patients with pathological T3N0M0 gastric cancer: A multi　institutional, retrospective study (YCOG2202).European Journal of Surgical Oncology,accepted October 22, 2024. DOI:https://doi.org/10.1016/j.ejso.2024.108782.